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Abstract
Background: CCR5 is a CC chemokine receptor involved in the migration of effector leukocytes including
macrophages, NK, and T cells into inflamed tissues. Also, the role of CCR5 in CD4+Foxp3+ regulatory T cell (Treg)
homing has recently begun to grab attention. Japanese encephalitis (JE) is defined as severe neuroinflammation of
the central nervous system (CNS) following infection with mosquito-borne flavivirus JE virus. However, the potential
contribution of CCR5 to JE progression via mediating CD4+Foxp3+ Treg homing has not been investigated.
Methods: Infected wild-type (Ccr5+/+) and CCR5-deficient (Ccr5−/−) mice were examined daily for mortality and
clinical signs, and neuroinflammation in the CNS was evaluated by infiltration of inflammatory leukocytes and
cytokine expression. In addition, viral burden, NK- and JEV-specific T cell responses were analyzed. Adoptive transfer
of CCR5+CD4+Foxp3+ Tregs was used to evaluate the role of Tregs in JE progression.
Results: CCR5 ablation exacerbated JE without altering viral burden in the extraneural and CNS tissues, as
manifested by increased CNS infiltration of Ly-6Chi monocytes and Ly-6Ghi granulocytes. Compared to Ccr5+/+ mice,
Ccr5−/− mice unexpectedly showed increased responses of IFN-γ+NK and CD8+ T cells in the spleen, but not CD4+
T cells. More interestingly, CCR5-ablation resulted in a skewed response to IL-17+CD4+ Th17 cells and
correspondingly reduced CD4+Foxp3+ Tregs in the spleen and brain, which was closely associated with exacerbated
JE. Our results also revealed that adoptive transfer of sorted CCR5+CD4+Foxp3+ Tregs into Ccr5−/− mice could
ameliorate JE progression without apparently altering the viral burden and CNS infiltration of IL-17+CD4+ Th17 cells,
myeloid-derived Ly-6Chi monocytes and Ly-6Ghi granulocytes. Instead, adoptive transfer of CCR5+CD4+Foxp3+ Tregs
into Ccr5−/− mice resulted in increased expression of anti-inflammatory cytokines (IL-10 and TGF-β) in the spleen and
brain, and transferred CCR5+ Tregs were found to produce IL-10.
Conclusions: CCR5 regulates JE progression via governing timely and appropriate CNS infiltration of CD4+Foxp3+
Tregs, thereby facilitating host survival. Therefore, this critical and extended role of CCR5 in JE raises possible safety
concerns regarding the use of CCR5 antagonists in human immunodeficiency virus (HIV)-infected individuals who
inhabit regions in which both HIV and flaviviruses, such as JEV and West Nile virus, are endemic.
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Background
The Flavivirus genus, which includes mosquito-borne
dengue virus, Japanese encephalitis (JE) virus, and West
Nile virus (WNV) [1–3], is associated with significant
morbidity and mortality due to fatal hemorrhagic fever
and encephalitis. Of the flaviviruses, Japanese encephal-
itis virus (JEV) continues to be the leading cause of viral
encephalitis in Asia and the Western Pacific. It poses an
increasing threat to global health and welfare, with
approximately 67,900 reported cases annually [4]. Due
to rapid changes in climate and demography, JEV is
currently spreading to previously unaffected regions
such as Indonesia, Pakistan, and northern Australia [5].
The incubation period of JEV ranges from 5 to 15 days
and is fatal in 25 to 30 % cases, mostly in infants, and a
high proportion of patients who survive have serious
neurological and psychiatric sequelae [4], for which JE is
considered to be more fatal than WNV encephalitis,
resulting in 3–5 % mortality (1100 death/29,000 symp-
tomatic infections) [6]. Pathologically, JE is a severe neu-
roinflammation in the central nervous system (CNS)
closely associated with the disruption of the blood–brain
barrier (BBB) [7]. Although little is known about the
pathogenesis of JEV, considerable progress has been
made in murine models [8, 9]. While JEV infects and
kills neurons directly in the CNS, CNS invasion of JEV
causes the stimulation of microglia/glia and infiltrated
leukocytes, leading to indirect neuronal killing via over-
secreting pro-inflammatory cytokines (such as IL-6 and
TNF-α) and soluble mediators that can induce neuronal
death [10, 11]. This notion implies that JE is an immu-
nopathological disease caused by uncontrolled over-
activation of innate and adaptive immune cells, resulting
in neurological disorders in the CNS. Therefore,
adequate CNS infiltration and activation of peripheral
immune cells is considered to play a critical role in pro-
tecting hosts from viral encephalitis such as JE. Indeed,
CNS infiltration and activation of peripheral leukocytes
during JE can cause profound damage if the reaction is
excessive or inappropriate [12]. Therefore, balanced
CNS infiltration and activation of peripheral leukocytes
should be achieved to have a favorable prognosis of JE
without tissue injury.
Chemokine-mediated influx of peripheral leukocytes
into the CNS is believed to clear infection, but also be re-
sponsible for deleterious bystander neuronal damage asso-
ciated with morbidity and, in some cases, increased
mortality. For example, CXCR3-deficient mice are found
to have enhanced CNS viral titers and mortality following
WNV infection [13], while these mice are protected from
lethal infection of lymphocytic choriomeningitis virus
(LCMV) or cerebral malaria [14, 15], suggesting that the
final outcome of encephalitis will depend on the nature of
the pathogen and a range of host factors. Likewise, CCR5
plays a critical role in recovery from flavivirus encephalitis
via appropriate CNS migration of peripheral leukocytes,
including NK cells and CD4+/CD8+ T cells [16–18].
Indeed, the important role of CCR5 in human host
responses to WNV encephalitis was demonstrated by a
retrospective cohort study involving persons homozygous
for CCR5Δ32 [19], a loss-of-function mutation found in
1–2 % of Caucasians [20]. Compared to individuals
without the mutation, persons carrying a homozygous
CCR5Δ32 allele have an increased risk of symptomatic
WNV infection. In view of the large number of human
infections caused by flaviviruses and their global distribu-
tion, there are concerns about the potential adverse out-
comes of CCR5 antagonist use for incurable infectious
diseases, including human immunodeficiency virus (HIV).
Furthermore, CD4+Foxp3+ regulatory T cells (Tregs),
which regulate excessive immune responses, are preferen-
tially accumulated over effector T cells at sites of disease
due to homing signals such as CCR5 [21–24]. CCR5-
dependent homing of CD4+Foxp3+ Tregs at infectious sites
in parasitic pathogen infection models has been shown to
promote pathogen persistence by regulating the magnitude
of pro-inflammatory responses and the equilibrium be-
tween IL-17+CD4+ Th17 and CD4+Foxp3+ Tregs [23, 24].
Recently, a putative role for CD4+Foxp3+ Tregs in the
pathogenesis of fatal acute inflammatory diseases caused by
flaviviruses has been suggested in the context of their regu-
latory function [25, 26]. However, the role of CD4+Foxp3+
Tregs in flavivirus encephalitis remains elusive due to a lack
of direct evidence. Presumably, CCR5-dependent recruit-
ment of CD4+Foxp3+ Tregs may affect the progression of
viral encephalitis via their regulatory function. To address
the direct regulation of JE by CD4+Foxp3+ Tregs in CCR5-
dependent homing context, we examined the role of CCR5
in JE progression using CCR5-deficient (Ccr5−/−) mice in
this study. Our results revealed that Ccr5−/− mice had exac-
erbated JE, ultimately resulting in high mortality without al-
tering CNS viral burden, NK response, or T cell response
compared to Ccr5+/+ mice. However, the increased sus-
ceptibility of Ccr5−/− mice to JE was closely associated
with decreased ratio of infiltrated CD4+Foxp3+ Treg to IL-
17+CD4+ Th17 in the CNS. This was directly confirmed by
the fact that injection of sorted CCR5+CD4+Foxp3+ Tregs
into Ccr5−/− mice provided ameliorated JE without affecting
CNS infiltration of IL-17+CD4+ Th17 cells or inflammatory
Ly-6Chi monocytes. Therefore, our data suggest that
CCR5 could dictate JE progression by tightly regulat-
ing the balance between infiltrated CD4+Foxp3+ Tregs
and IL-17+CD4+ Th17 cells in the CNS.
Methods
Animals
C57BL/6 (H-2b) mice (4- to 6-week-old female or male)
were purchased from Samtako (O-San, Korea). CCR5
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deficient (Ccr5−/−) mice and Foxp3GFP knock-in mice
(H-2b), which co-express EGFP and regulatory T cell-
specific transcription factor Foxp3 under the control of
an endogenous promoter, were obtained from Jackson
Laboratories (Bar Harbor, ME). Ccr5−/−·Foxp3GFP mice
were generated by crossing Ccr5−/− mice with Foxp3GFP
knock-in mice. All mice were genotyped and bred in the
animal facilities of Chonbuk National University.
Cells, viruses, antibodies, and reagents
JEV Beijing-1 strain was obtained from the Green Cross
Research Institute (Suwon, Korea) and propagated in a
mosquito cell line (C6/36) using DMEM supplemented
with 2 % fetal bovine serum (FBS), penicillin (100 U/ml),
and streptomycin (100 U/ml) [27]. C6/36 cells were in-
fected with JEV Beijing-1 at a multiplicity of infection
(MOI) of 0.1 and incubated in a humidified CO2 incuba-
tor at 28 °C for 1 h. After absorption, the inoculum was
removed and 7 ml of maintenance medium containing
2 % FBS was added. At approximately 6–7 days post-
infection (dpi), cultures of host cells showing 80–90 %
cytopathic effect (CPE) were harvested. Virus stocks
were titrated by conventional plaque assay or focus-
forming assay and stored in aliquots at −80 °C until use.
Monoclonal antibodies used for flow cytometric analysis
and other experiments were obtained from eBioscience
(San Diego, CA) or BD Biosciences (San Diego, CA),
including fluorescein isothiocynate (FITC)-conjugated
anti-CD3ε (154-2C11), Ly6G (1A8), CD8 (53-67), phyco-
erythrin (PE)-conjugated anti-mouse CD11b (M1/70),
Foxp3 (FJK-16s), IFN-γ (XMG1.2), F4/80(BM8), gran-
zyme B (NGZB), peridinin chorophyll protein complex
(PerCP)-conjugated anti-mouse Ly6C (HK 1.4), PE-
cyanine dye (Cy7)-anti-mouse NK1.1 (PL136), allophy-
cocyanin (APC)-conjugated anti-mouse CD45(30-F11),
IL-17 (eBio17B7), TNF-α (MP6-XT22), biotin-
conjugated anti-mouse IL-10 (JES5-16E3), and CD49b
(DX5). Peptides of the defined I-Ab-restricted epitopes
JEV NS1132–145 (TFVVDGPETKECPD), NS3563–574
(WCFDGPRTNAIL), and H-2Db-restricted epitope JEV
NS4B215–223 (SAVWNSTTA) were chemically synthe-
sized at Peptron Inc. (Daejeon, Korea). JEV-specific
primers for viral RNA detection and primers specific for
cytokines, chemokines, and transcription factors
(Table 1) were synthesized at Bioneer Corp. (Daejeon,
Korea) and used for PCR amplification of target genes.
Quantitative real-time RT-PCR for determination of viral
burden and cytokine expression
Viral burden and the expression of cytokines (IL-1β, IL-6,
IL-10, IL-17, IFN-γ) and chemokines (CCL2, CCL3, CCL4,
CCL5, CXCL1, CXCL2) in inflammatory and lymphoid
tissues were determined using quantitative SYBR Green-
based real-time RT-PCR (real-time qRT-PCR). Mice were
intraperitoneally (i.p.) infected with JEV (3.0 × 107 pfu).
Tissues including brain and spleen were harvested at 3, 4, 5,
and 7 dpi following extensive cardiac perfusion with Hank’s
balanced salt solution (HBSS). Total RNAs were extracted
from tissues using easyBLUE (iNtRON, Inc., Daejeon,
Korea). Reverse transcription of total RNAs was performed
using High-Capacity cDNA Reverse Transcription Kits
(Applied Biosystems, Foster, CA). These complementary
DNAs (cDNAs) were used for real-time qPCR using a
CFX96 Real-Time PCR Detection system (Bio-Rad Labora-
tories, Hercules, CA). The reaction mixture contained 2 μl
of template cDNA, 10 μl of 2× SYBR Primix Ex Taq, and
200-nM primers at a final volume of 20 μl. The reactions
were denatured at 95 °C for 30 s and then subjected to 45 cy-
cles of 95 °C for 5 s and 60 °C for 20 s. After the reaction
cycle was completed, the temperature was increased from
65 to 95 °C at a rate of 0.2 °C/15 s, and the fluorescence was
measured every 5 s to construct a melting curve. A control
sample containing no template DNA was run with each
assay, and all determinations were performed at least in du-
plicates to ensure reproducibility. The authenticity of ampli-
fied product was determined by melting curve analysis.
Viral RNA burden in infected samples was expressed as
viral RNA copies per microgram of RNA. The expression
levels of cytokines and chemokines were normalized to β-
actin. All data were analyzed using Bio-Rad CFX Manager
version 2.1 analysis software (Bio-Rad Laboratories).
Infiltrated leukocyte analysis in the CNS
Mice infected with JEV were perfused with 30 ml of
HBSS at 3, 5, and 7 dpi via cardiac puncture of the left
ventricle. The brains were harvested and homogenized
by gently pressing them through 100-mesh tissue sieves,
after which they were digested with 25 μg/ml of collage-
nase type IV (Worthington Biochem, Freehold, NJ),
0.1 μg/ml trypsin inhibitor Nα-p-tosyl-L-lysine chloro-
methyl ketone, 10 μg/ml DNase I (Amresco, Solon, OH),
and 10 mM HEPE in HBSS at 37 °C for 1 h with shak-
ing. Cells were separated using Optiprep density gradi-
ent (18/10/5 %) centrifugation at 800×g for 30 min
(Axis-Shield, Oslo, Norway), after which cells collected
from the 18 to 10 % interface were washed twice with
PBS. Cells were then counted and stained for CD11b,
Ly6G, Ly6C, CD45, F4/80, CD3, CD4, CD8, and NK1.1
using directly conjugated antibodies (eBioscience) at 4 °C
for 30 min. Finally, these cells were fixed with 10 % for-
maldehyde. Data collection and analysis were performed
with a FACS Calibur flow cytometer (Becton Dickson
Medical Systems, Sharon, MA) and the FlowJo (Tree Star,
San Carlos, CA) software, respectively.
Analysis and activation of NK cells
The activity of NK cells was assessed by their capacity to
produce IFN-γ following brief stimulation with PMA and
Kim et al. Journal of Neuroinflammation  (2016) 13:223 Page 3 of 19
ionomycin (Sigma-Aldrich). Briefly, splenocytes were pre-
pared from Ccr5+/+ and Ccr5−/− mice at 2 dpi and stimu-
lated with PMA and ionomycin (PMA at 50 ng/ml,
ionomycin at 750 ng/ml) in the presence of monensin
(2 μM) to induce the expression of IFN-γ for 1 h. After
stimulation, cells were surface-stained with FITC-anti-
mouse-CD3ε, PE-Cy7 anti-mouse NK1.1, biotin-conjugated
anti-mouse pan-NK cells (CD49b) [DX5] antibodies, and
streptavidin-APC at 4 °C for 30 min. Cells were then
washed twice with FACs buffer containing monensin. After
fixation, cells were permeabilized with 1× permeabilization
buffer (eBioscience) and stained intracellularly with PE
anti-mouse IFN-γ (XMF1.2) antibody in permeabilization
buffer at room temperature for 30 min. After cells were
washed with PBS twice, analysis was performed using a
FACS Calibur flow cytometer and FlowJo software.
JEV-specific CD4+ and CD8+ T cell responses
To monitor CD4+ and CD8+ T cell responses specific for
JEV, surviving mice were sacrificed at 7 dpi and splenocytes
Table 1 Specific primers for the expression of cytokines, chemokines, transcription factor, and JEV RNA used in real-time qRT-PCR
Gene name Primer sequence (5′-3′) Position cDNA Gene bank ID
IL-1β FP: AAGTGATATTCTCCATGAGCTTTGT 535–559 NM_008361
RP: TTCTTCTTTGGGTATTGCTTGG 679–700
IL-6 FP: TGG GAA ATC GTG GAA ATG AG 209–228 NM_031168
RP: CTC TGA AGG ACT CTG GCT TTG 442–462
IL-10 FP: CAA CAT ACT GCT AAC CGA CTC CT 253–275 NM_010548
RP: TGA GGG TCT TCA GCT TCT CAC 405–425
IL-17 FP: TCT GAT GCT GTT GCT GCT G 87–105 NM_010552.3
RP: ACG GTT AGA GGT AGT CTG AGG 254–267
IFN-γ FP: CAG CAA CAA CAT AAG CGT CA 119–220 NM_008337.3
RP: CCT CAA ACT TGG CAA TAC TCA
CCL2 FP: AAA AAC CTG GAT CGG AAC CAA 347–367 NM_011333
RP: CGG GTC AAC TTC ACA TTC AAA G 426–447
CCL3 FP: CCA AGT CTT CTC AGC GCC AT 158–177 NM_011337.2
RP: GAA TCT TCC GGC TGT AGG AGA AG 206–228
CCL4 FP: TTC TGT GCT CCA GGG TTC TC 128–147 NM_013652.2
RP: GAG GAG GCC TCT CCT GAA GT 388–407
CCL5 FP: CCC TCA CCA TCA TCC TCA CT 77–96 NM_013653.3
RP: CTT CTT CTC TGG GTT GGC AC 275–294
CXCL1 FP: CGC TGC TGC TGC TGG CCA CC 101–120 NM_008176.3
RP: GGC TAT GAC TTG GGT TTG GG 245–264
CXCL2 FP: ATC CAG AGC TTG AGT GTG ACG C 194–215 NM_009140.2
RP: AAG GCA AAC TTT TTG ACC GC 264–283
FOXP3 FP: GGC CCT TCT CCA GGA CAG A 551–570 NM_054039.2
RP: GCT GAT CAT GGC TGG GTT GT 642–662
GATA3 FP: AGT CCT CAT CTC TTC ACC TTC C 1027–1048 NM_008091.3
RP: GGC ACT CTT TCT CAT CTT GCC TG 1116–1138
RORγt FP: CCG CTG AGA GGG CTT CAC 75–93 AJ1232394
RP: TGC AGG AGT AGG CCA CAT TAC 283–304
T-bet FP: GCC AGG GAA CCG CTT ATA TG 823–843 AF241242
RP: GAC GAT CAT CTG GGT CAC ATT GT 935–958
JEV FP: GGC TTA GCG CTC ACA TCC A 4132–4150 AB920399.1
RP: GCT GGC CAC CCT CTC TTC TT 4207–4226
β-actin FP: TGG AAT CCT GTG GCA TCC ATG AAA C 885–909 NM_007393.3
RP: TAA AAC GCA GCT CAG TAA CAG TCC G 1209–1233
IL interleukin, FP forward primer, RP reverse primer
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were prepared. Erythrocytes were depleted by treating
single-cell suspensions with ammonium chloride-
containing Tris buffer (NH4Cl-Tris) at 37 °C for 5 min.
These splenocytes were then cultured in 96-well culture
plates (5 × 105 cells/well) with synthetic peptide epitopes
(NS1132–145, NS3563–575, or NS4B215–225) in the pres-
ence of anti-CD154-PE for 12 h or for 6 h to evaluate
CD4+ orCD8+ T cell responses, respectively [28, 29].
Monensin (2 μM) was added to the antigen-
stimulated cells 6 h before harvest. Cells were washed
with PBS twice and surface-stained with FITC-anti-
CD4 or CD8 antibodies at 4 °C for 30 min, followed by
washing twice with PBS containing monensin. After fix-
ation, cells were washed twice with permeabilization buf-
fer and stained with PE-anti-IFN-γ and APC-anti-TNF-α
antibodies in permeabilization buffer at room temperature
for 30 min. Finally, cells were washed twice with PBS and
fixed using fixation buffer. Samples were analyzed using a
FACS Calibur flow cytometer and FlowJo software.
Intracellular staining for analysis of CD4+ Th1, Th17, and
Treg cells
To monitor CD4+ Th subsets, mice were infected i.p.
with 3.0 × 107 pfu of JEV and sacrificed at 3 and 5 dpi.
Brain leukocytes and splenocytes were prepared and cul-
tured in 96-well plates (106 cells/well) with PMA/iono-
mycin (Th1 and Th17) in the presence of monensin
(2 μM) at 37 °C for 5 h. Stimulated cells were washed
twice with PBS and surface-stained with FITC-anti-CD4
at 4 °C for 30 min. After washing twice with PBS con-
taining monensin and fixation, cells were washed twice
with permeabilization buffer (eBioscience, SanDiego, CA)
and then stained with PerCP-anti-IFN-γ and APC-anti-IL-
17α in permeabilization buffer at room temperature for
30 min. After washing twice with PBS, cells were fixed
with fixation buffer. To monitor Treg cells, brain leuko-
cytes and splenocytes were surface-stained with FITC-
anti-CD4 markers on ice for 30 min, followed by fixation
with permeabilization concentrate buffer (eBioscience,
sSan Diego, CA) at 4 °C for 6 h. After fixation, cells were
washed twice with permeabilization and stained with PE-
anti-Foxp3 in permeabilization buffer at room
temperature for 30 min. Sample analysis was performed
with a FACS Calibur flow cytometer.
Purification and trafficking analysis of CCR5+CD4+ Foxp3+
Treg cells
CCR5+CD4+Fopx3+ Treg cells were isolated from the
spleen of Foxp3GFP knock-in mice using a FACS Aria
sorter (Becton Dickson, Palo Alto, CA) with a final cell
purity of ≥95 %. CCR5+CD4+Fopx3+ Treg cells were resus-
pended at density of 107 cells/ml in RPMI 1640 complete
medium containing 10 % FBS, 1 % L-glutamine, 1 %
nonessential amino acids, and 1 % penicillin/streptomycin.
CCR5+CD4+Foxp3+Treg cells (2 × 106 cells/mouse) were
injected intravenously into JEV-infected Ccr5−/− mice at
3 dpi. After injecting donor cells, brain and spleen tissues
were harvested at 5 dpi. Infiltrated cells were analyzed for
the presence of GFP-labeled cells using a FACS Calibur
flow cytometer. CCR5−CD4+Fopx3+ Treg cells were puri-
fied from Ccr5−/−·Foxp3GFP mice and adoptively
transferred into Ccr5−/− mice for the control group to
CCR5+CD4+Foxp3+ Treg-recipients. In some experiments,
IL-10-producing CCR5+CD4+Foxp3GFP Tregs were de-
tected by intracellular IL-10 staining combined with sur-
face staining with CCR5 and CD4.
Statistical analysis
All data are expressed as averages ± standard deviation.
Statistically significant differences between groups were
analyzed using an unpaired two-tailed Student’s t test for
leukocyte population analysis and in vitro experiments or
ANOVA and post hoc testing for multiple comparisons of
the means. The significance of differences in viral burden
and in vivo cytokine gene expression was evaluated by
Mann-Whitney test or unpaired two-tailed Student’s t test.
Kaplan-Meier survival curves were analyzed using the log-
rank test. A p value ≤0.05 was considered to indicate stat-
istical significance. All data were analyzed using the Prism
software (GraphPad Prism 4, San Diego, CA).
Results
CCR5 is essential for protection against JE but
dispensable for control of viral replication
The chemokine receptor CCR5 is believed to play a crit-
ical role in recovery from flavivirus encephalitis via effi-
cient leukocyte trafficking to the brain [16–18]. CCR5 is
also a key mediator to recruit CD4+Foxp3+ Tregs known
as regulatory CD4+ T cell subset to dampen exacerbated
inflammation such as viral encephalitis [21–24]. Although
the role of CD4+Foxp4+ Tregs in flavivirus encephalitis re-
mains elusive, CCR5-dependent recruitment of CD4
+Foxp3+ Tregs may play certain roles in the control of en-
cephalitis progression caused by flavivirus infection. To
address this issue of CCR5 in flavivirus encephalitis, we
first confirmed the role of CCR5 in JE progression using
CCR5-deficient (Ccr5−/−) mice. After Ccr5+/+ and Ccr5−/−
mice were infected with JEV, surviving mice were moni-
tored until 15 dpi (Fig. 1a). Mice in both groups showed
similar clinical signs, starting with generalized piloerec-
tion, paresis, and rigidity and followed by progression into
severe neurological signs such as postural imbalance,
ataxia, and generalized tonic-clonic seizure from 4 to
6 dpi. However, CCR5 ablation resulted in marked in-
creases in mortality after showing neurological disorders,
with a mortality rate of 100 % for Ccr5−/− mice vs. 54 %
for Ccr5+/+ mice after JEV infection (3.0 × 107 pfu). Like-
wise, Ccr5−/− mice showed a rapid increase in the
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frequency of neurological disorder starting from 3 to 4 dpi
after JEV infection (3.0 × 107 pfu) with greater body weight
loss, compared to Ccr5+/+ mice (Fig. 1b, c). However, the
viral burden in the extraneural lymphoid tissue (spleen)
and CNS (brain and spinal cord) of Ccr5−/− mice was not
increased compared to that of Ccr5+/+ mice (Fig. 1d).
Therefore, these results indicate that CCR5 ablation could
result in an increased susceptibility to JE progression irre-
spective of viral replication.
CCR5 ameliorates JE progression
To further characterize CNS inflammation caused by JEV
infection in Ccr5+/+ and Ccr5−/− mice, we assessed the in-
filtration of CD11b+Ly-6Chi monocytes and CD11b+Ly-
6Ghi granulocytes into CNS, because infiltration of these
cell populations derived from the myeloid cell lineage has
been used to evaluate CNS inflammation [30]. Our results
revealed that a markedly higher frequency of infiltrated
CD11b+Ly-6Chi monocytes and CD11b+Ly-6Ghi granulo-
cytes was retained in the brain of Ccr5−/− mice at 3, 5, and
7 dpi, compared to that in the brain of Ccr5+/+ mice
(Fig. 2a). Similarly, the absolute number of CD11b+Ly-
6Chi monocytes and CD11b+Ly-6Ghi granulocytes infil-
trating the brain of Ccr5−/− mice was increased two- and
threefold at 5 dpi, respectively (Fig. 2b). Moreover,
microglia cells contribute to the progression of encephal-
itis caused by some neurotropic viruses, such as WNV
[31, 32]. Thus, four-color (CD11c/CD11b/CD45/F4/80)
staining was used to distinguish resting from activated
microglia. Based on the CNS myeloid cell classification
method of Ford et al. [33], equivalent percentages and simi-
lar absolute numbers of resting microglia (CD11c
−CD11bhiCD45intF4/80+) were detected in both Ccr5+/+
and Ccr5−/− mice. However, activated microglia/macro-
phages (CD11c−CD11bhiCD45hiF4/80+) and other myeloid-
derived leukocytes (CD11c−CD11bintCD45hiF4/80+) in the
brain of Ccr5−/− mice were detected at higher frequencies
and absolute numbers compared to the brain of Ccr5+/+
mice (Fig. 2c, d). These results indicate that CCR5 ablation
could exacerbate JE by enhancing the accumulation of
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Fig. 1 CCR5 is essential for protection against JE but dispensable for control of JEV replication. a Susceptibility of CCR5-ablated mice to JE. Ccr5+/+ and
Ccr5−/− mice (4 to 6 weeks old, n = 10–15) was inoculated i.p. with JEV (3.0 × 107 pfu). The survival rate was examined over 15 days. b Ratio of mice
showing neurological disorders during JE progression. Mice infected with JEV were examined every 6 h from 4 to 8 dpi. c Changes in body weight.
Data are average percentages ± SD of body weight relative to that at the time of challenge. d Viral burden in lymphoid and inflammatory tissues
during JE. Viral burden in lymphoid (spleen) and inflammatory tissues (brain and spinal cord) of infected mice (n = 5–6) were assessed by real-time
qRT-PCR at the indicated time points. Viral RNA load was expressed as viral RNA copy number per microgram of total RNA (n = 5–7). *p < 0.05;
**p < 0.01 compared to the levels in the corresponding groups
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inflammatory monocytes and granulocytes in the CNS,
along with activation of microglia. CCR5 is also considered
to be involved in the recruitment of lymphoid lineage-
derived cells, including CD4+, CD8+ T cells, and NK cells
[34, 35], which may play a beneficial role in the control of
JE progression [36–38]. To better understand CNS inflam-
mation in Ccr5−/− mice following JEV infection, CD4+ and
CD8+ T cells, and NK cells were enumerated in the brain.
Infiltration of both CD4+ and NK cells was evidenced by a
transient increase in Ccr5+/+ mice at 3 dpi, after which the
total number of CD4+ and NK cells in Ccr5+/+ and Ccr5−/−
mice was comparable at 5 and 7 dpi. This result implies
that CD4+ T and NK cells might not predominate in the
control of JE that has already progressed, because infected
mice usually showed clinical signs at around 4–5 dpi.
However, CD8+ T cells infiltrated the brain of Ccr5−/− mice
at gradually increased levels up to 5 dpi compared to that
in the brain of Ccr5+/+ mice (Fig. 2e), indicating that en-
hanced infiltration of CD8+ T cells is closely associated with
JE progression.
In terms of CNS inflammation, the expression of cyto-
kines and chemokines within the CNS is required for en-
cephalitis, because encephalitis caused by neurotropic
viruses is indirectly derived from CNS degeneration, due to
robust immunological responses such as uncontrolled se-
cretion of cytokines and chemokines, which results in the
activation of microglia and astrocytes [10, 11]. Therefore,
we examined the expression of cytokines and chemokines
in the CNS. We found that CCR5 ablation resulted in early
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Fig. 2 CCR5 regulates JE progression by altering the infiltration of leukocytes in the brain. a, b The frequency and number of Ly-6Chi monocytes and
Ly-6Ghi granulocytes in the brain. Ccr5+/+ and Ccr5−/− mice were inoculated i.p. with JEV (3.0 × 107 pfu), and the frequency (a) and total number (b) of
Ly-6Chi monocytes and Ly-6Ghi granulocytes in the CNS were determined by flow cytometric analysis at 3, 5, and 7 dpi using vigorous heart perfusion.
Values in representative dot-plots denote the average percentage of the indicated population after gating on CD11b+ cells. c, d Resting and activated
microglia/macrophage number in the CNS. The number of resting (CD11c−CD11bhiCD45intF4/80+) and activated (CD11c-CD11bhiCD45hi F4/80+) as well
as other myeloid-derived leukocytes (CD11bintCD45hi F4/80+) was enumerated using flow cytometric analysis at 3 dpi. Values in representative dot-
plots denote the average percentage of the indicated population after gating on CD11c−F4/80+ cells. e Accumulated number of NK cells, CD4+, and
CD8+ T cells in the CNS. Total accumulated number of NK cells (CD3−NK1.1+DX5+), CD4+ (CD3+CD4+), and CD8+ (CD3+CD8+) T cells in the CNS were
enumerated using flow cytometric analysis at 3, 5, and 7 dpi. Data are averages ± SD of the indicated cell populations derived from at least three
independent experiments (n = 4–5). *p < 0.05; **p < 0.01; ***p < 0.001 compared with the levels of the indicated groups
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cytokines at 3 dpi. However, IFN-γ expression was higher
in Ccr5+/+ mice at 3 dpi, compared to in Ccr5−/− mice. The
early increase in CNS infiltration of CD4+ and NK cells
likely led to earlier and higher expression of IFN-γ. In
addition, it was interesting that the expression levels of
some cytokines were reversed at 5 dpi (Fig. 3a). Notably,
the anti-inflammatory cytokine IL-10 was expressed at
higher levels in Ccr5+/+ mice at 5 dpi, whereas IL-17, which
is produced by CD4+ Th17 cells, was expressed at a lower
level in Ccr5+/+ mice compared to those in Ccr5−/− mice at
5 dpi. With regard to chemokine expression, CC chemo-
kines were expressed at higher levels in Ccr5−/− mice 4 dpi
compared to those in Ccr5+/+ mice. Interestingly, the ex-
pression levels of CXC chemokines, CXCL1 and CXCL2,
were enhanced in Ccr5−/− mice at 3 dpi, and such expres-
sion was reversed at 5 dpi (Fig. 3b). Collectively, these re-
sults indicate that the expression levels of pro-/anti-
inflammatory cytokines and CC/CXC chemokines in the
CNS of Ccr5+/+ and Ccr5−/− mice could change dynamic-
ally depending on the progression of JE.
Kinetic analysis of myeloid and lymphoid cells in the
spleen and blood of CCR5-ablated mice
Because the CNS expression pattern of CC and CXC che-
mokines in Ccr5+/+ and Ccr5−/− mice differed according to
JE progression, this CC/CXC chemokine expression may
affect the migration of myeloid and lymphoid cells, includ-
ing monocytes, granulocytes, NK, and T cells in both Ccr5
+/+ and Ccr5−/− mice. Therefore, to better understand the
recruitment of myeloid and lymphoid cells in the CNS, we
kinetically examined the number of myeloid and lymphoid
cells in the spleen and blood of Ccr5+/+ and Ccr5−/− mice
depending on JE progression. In addition, analyzing the
spleen could provide insight into how CCR5 modulates in-
nate and inflammatory responses immediately after infec-
tion. Analysis of myeloid CD11b+ and lymphoid CD8α+
DC subsets revealed that both Ccr5+/+ and Ccr5−/− mice
exhibited a similar reduction in the spleen (Fig. 4a), as wild-
type mice have been previously shown to have a transiently
decreased number of myeloid and lymphoid DCs due to
JEV infection [27]. However, Ccr5−/− mice had higher num-
bers of inflammatory CD11b+Ly-6Chi monocytes and Ly-
6Ghi neutrophil in the spleen up to 5 dpi, compared to
Ccr5+/+ mice (Fig. 4b), indicating that Ccr5−/− mice experi-
enced a severe inflammatory reaction in the spleen. Also,
the absolute number of splenic CD3-NK1.1+DX5+ NK cells
was transiently decreased in both Ccr5+/+ and Ccr5−/−
mice, but Ccr5+/+ mice had a higher number of CD3
−NK1.1+DX5+ NK cells in the spleen at the early phase (1
and 2 dpi), compared to Ccr5−/− mice (Fig. 4c). Interest-
ingly, our results revealed that the frequency and number
of NK cells producing IFN-γ were increased in Ccr5−/−
mice, rather than in Ccr5+/+ mice, when the activation of
NK cells was evaluated by assessing their production of
IFN-γ (Fig. 4d). These data indicate that NK cells might not
be involved in the amelioration of JE in Ccr5+/+ mice. Fur-
thermore, our results revealed that the number of Ly-6Chi
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Fig. 3 The dynamic expression of cytokines and chemokines in CCR5-ablated mice, depending on JE progression. a Expression of pro- and
anti-inflammatory cytokines in the CNS. b The expression of CC and CXC chemokines in the CNS. The expression of cytokines and chemokines
in the CNS was determined by real-time qRT-PCR at the indicated time points after Ccr5+/+ and Ccr5−/− mice were inoculated i.p. with JEV
(3.0 × 107 pfu). Data are averages ± SD of β-actin-normalized cytokine expression derived from at least three independent experiments (n = 4–5).
*p < 0.05; **p < 0.01 compared with the levels of the indicated groups
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the infiltration trends of Ly-6Chi monocytes and Ly-6Ghi
neutrophils in the brain. CCR5-ablated mice had higher
numbers of Ly-6Chi monocytes and Ly-6Ghi neutrophils in
the blood up to 5 dpi, compared to Ccr5−/− mice (Fig. 4f).
Also, NK cells in the blood of Ccr5−/− mice were detected
at transiently lower levels at the early phase (1 and 2 dpi),
after which they were comparable in Ccr5+/+ and Ccr5−/−
mice (Fig. 4g). CD4+ T cell numbers were transiently higher
number in the blood of Ccr5+/+ mice than in Ccr5−/− mice
at 2 and 3 dpi, but CD8+ T cells accumulated to higher
levels in Ccr5−/− mice, rather than Ccr5+/+ mice, at up to
5 dpi (Fig. 4h). Therefore, these results suggest that CCR5
ablation is not involved in the migration of myeloid and
lymphoid cells from the blood into the brain during JE
progression.
Adaptive T cell immune responses in CCR5-ablated mice
Antiviral adaptive immune responses, including those me-
diated by effector antigen-specific CD4+ and CD8+ T cells,
are required for the regulation of JE progression through
the control and clearance of JEV in extraneural lymphoid
tissues and the CNS [36–38]. Although both Ccr5+/+ and
Ccr5−/− mice infected with JEV exhibited neurological dis-
orders at 4–5 dpi, which is before functional adaptive im-
mune responses were fully induced, we examined the
generation of JEV-specific CD4+ T cell responses in surviv-
ing Ccr5+/+ and Ccr5−/− mice at 7 dpi using intracellular
CD154 staining combined with intracellular cytokine IFN-
γ staining, because CD154+CD4+ T cells could enable us
to enumerate viable JEV-specific CD4+ T cells in response
to stimulation with epitope peptides [28, 29]. As shown in
Fig. 5a, b, similar levels of JEV-specific CD154+CD4+ T
cells were detected in Ccr5+/+ and Ccr5−/− mice. However,
the frequencies of JEV-specific CD4+ T cells producing
IFN-γ were higher in Ccr5+/+ mice upon stimulation with
the epitope peptides NS1132–145 and NS3563–574, compared
to those in Ccr5−/− mice. Also, IFN-γ+CD4+ T cell num-
bers were higher in the spleen of Ccr5+/+ mice upon
a









































































































































































































































































































































































































































































Fig. 4 Kinetic analysis of DC subpopulations, myeloid cells, NK cells, and CD4/CD8 T cells in the spleen and blood of CCR5-ablated mice. a–c Kinetic
analysis of DC subpopulations, Ly-6Chi monocytes, Ly-6Ghi neutrophils, and NK cells in the spleen. Ccr5+/+ and Ccr5−/− mice were inoculated i.p. with
JEV (3.0 × 107 pfu), and the absolute numbers of splenic DC subpopulations (CD11c+CD11b+ myeloid DC and CD11c+CD8α+ lymphoid DC) (a), Ly-6Chi
monocytes and Ly-6Ghi neutrophils (b), and NK cells (c) were determined using flow cytometric analysis at the indicated time points. d Activation of
NK cells. The activation of CD3−NK1.1+DX5+ NK cells was evaluated by intracellular IFN-γ staining upon stimulation with PMA plus ionomycin. Values in
the histograms on the left denote the average percentages of IFN-γ-producing cells after gating on CD3−NK1.1+DX5+ NK cells. e Absolute number of
CD4+ and CD8+ T cells in the spleen. Splenic CD4+ and CD8+ T cells were enumerated from 1 to 7 dpi. f–h Kinetic analysis of myeloid, NK, and T cells
in the blood of Ccr5+/+ and Ccr5−/− mice. The numbers of myeloid cells (Ly-6Chi monocytes and Ly-6Ghi neutrophils) (f), NK cells (g), and CD4+/CD8+ T
cells (h) were determined using flow cytometric analysis at the indicated time points. Data are averages ± SD of values derived from at least three
independent experiments (n = 3–5). *p < 0.05; **p < 0.01; ***p < 0.001 compared to the levels in the corresponding groups
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stimulation with JEV epitope peptides at 7 dpi, compared
to Ccr5−/− mice (Fig. 5c, d). Presumably, this increase in
IFN-γ+CD4+ T cells specific for JEV Ag may contribute
in part to the control of JE progression in Ccr5+/+
mice at a later phase. In contrast, the frequency and
total number of JEV-specific CD8+ T cells producing IFN-
γ and TNF-α in response to stimulation with the CD8+ T
cell epitope NS4B215–223 were higher in Ccr5
−/− mice than
in Ccr5+/+ mice (Fig. 5e, f ). This result was inconsistent
with the enhanced CNS infiltration of CD8+ T cells. Taken
together, these results suggest that antiviral JEV-specific
CD8+ T cells may not be key players in the control of JE
progression in Ccr5+/+ mice at the early phase (4–5 dpi).
However, IFN-γ+CD4+ T cells specific for JEV Ag appear
to play a role in the control of JE progression in Ccr5+/+


























































































































































































































Fig. 5 Adaptive T cell responses of CCR5-ablated mice following JEV infection. a–d JEV-specific CD4+ T cell responses. e, f JEV-specific CD8+ T cell
responses. Splenocytes prepared from surviving mice at 7 days following JEV (3.0 × 107 pfu) infection were stimulated with JEV epitope peptide of
CD4+ T cells (a, c NS1132–145; b, d, NS3563–574) and of CD8
+ T cells (e, f NS4B215–223) for 12 and 6 h, respectively. The frequency and absolute number of
JEV-specific CD4+ and CD8+ T cells were evaluated by intracellular CD154 and cytokine (IFN-γ or TNF-α) staining combined with CD4 and CD8 surface
staining. Values in representative dot-plots are the average percentage of the indicated cell population, while bar charts show the average ± SD of
values derived from at least three independent experiments (n = 3–4). *p < 0.05; **p < 0.01 compared with the levels of the indicated groups
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Skewed IL-17+CD4+ Th17 responses of CCR5-ablated mice
during JE progression
NK and CD8+ T cells did not appear to play a dominant
regulatory function in already progressed JE because
Ccr5+/+ mice failed to show enhanced CNS infiltration
of NK or CD8+ T cells at 5 dpi, compared to Ccr5−/−
mice. In addition, a stronger JEV-specific CD8+ T cell re-
sponse was elicited in Ccr5−/− mice at 7 dpi, rather than
Ccr5+/+ mice. Although the IFN-γ+CD4+ Th1 response
specific for JEV Ag was stronger in Ccr5+/+ mice, adap-
tive JEV-specific CD4+ T cell responses take some time
to develop. Therefore, adaptive JEV-specific CD4+ T cell
responses may contribute to the control of JE progres-
sion only at a later stage. In our results, dynamic
changes in the expression of pro-/anti-inflammatory cy-
tokines, particularly IL-10 and IL-17, were observed in
the CNS during JE progression at 3 and 5 dpi. Therefore,
we evaluated the dynamic response of CD4+ Th subsets
that produce typical pro- or anti-inflammatory cytokines:
CD4+ Th1 expressing IFN-γ, CD4+ Th17 expressing IL-17,
and CD4+Foxp3+ Tregs expressing IL-10. First, we exam-
ined the frequency and total number of CD4+Foxp3+ Tregs
in the spleens of Ccr5+/+ and Ccr5−/− mice at 3 and 5 dpi, a
time point at which the mice showed dynamic changes in
cytokine expression. Ccr5+/+ mice exhibited a significantly
higher frequency and number of CD4+Foxp3+ Tregs at
both 3 and 5 dpi, compared to Ccr5−/− mice (Fig. 6a). How-
ever, Ccr5−/− mice showed an increased frequency and total
number of CD4+ Th1 expressing IFN-γ and CD4+ Th17 ex-
pressing IL-17 in the spleen at both 3 and 5 dpi, compared
to Ccr5+/+ mice (Fig. 6b). This result indicates that Ccr5−/−




















































































































































































































































































Fig. 6 Early skewed IL-17+CD4+ Th17 response of CCR5-ablated mice during JE progression. a, b Frequency and number of CD4+Foxp3+ Tregs,
IFN-γ+CD4+ Th1, and IL-17+CD4+ Th17 cells in the spleen of CCR5-ablated mice. c, d Frequency and number of CD4+Foxp3+ Tregs, IFN-γ+CD4+
Th1, and IL-17+CD4+ Th17 cells in the brain of CCR5-ablated mice. The frequency and absolute number of CD4+Foxp3+ Tregs (a, c), IFN-γ+CD4+
Th1, and IL-17+CD4+ Th17 cells (b, d) in the spleen (a, b) and brain (c, d) of Ccr5+/+ and Ccr5−/− mice were determined by flow cytometric
analysis at 3 and 5 days following JEV (3.0 × 107 pfu) infection. CD4+Foxp3+ Tregs were detected with intracellular Foxp3 and surface CD4 staining,
and the frequency and number of IFN-γ+CD4+ Th1 and IL-17+CD4+ Th17 cells were determined by intracellular cytokine staining in response to
PMA + ionomycin stimulation of splenocytes or brain leukocytes prepared from Ccr5+/+ and Ccr5−/− mice. Values in representative dot-plots are
the average percentage of Foxp3+ cells, IFN-γ+ and IL-17+ in CD4+ T cells. e Expression of transcription factors by CNS-infiltrated CD4+ T cells.
After vigorous heart perfusion, sorted CD4+ T cells from CNS-infiltrated leukocytes were briefly stimulated with PMA plus ionomycin for 3 h.
The expression of transcription factors of CD4+ Th1, Th2, Th17, and Tregs was determined by real-time qRT-PCR using total RNA extracted from
stimulated CD4+ T cells. Data are averages ± SD of values derived from at least three independent experiments (n = 3–4). *p < 0.05; **p < 0.01;
***p < 0.001 compared with the levels of the indicated groups
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the early stage of JE progression. To further define the
skewed response of the CD4+ Th subsets in Ccr5−/− mice,
we examined CNS-infiltrated CD4+ Th subsets at 3 and
5 dpi during JE progression. Ccr5+/+ mice showed a rapidly
increased frequency and absolute number of CNS-
infiltrated CD4+Foxp3+ Tregs; levels were two- to threefold
higher than those of Ccr5−/− mice (Fig. 6c). Also, Ccr5+/+
mice exhibited a moderately increased number, but not fre-
quency, of CD4+ Th1 expressing IFN-γ in the CNS at 3
and 5 dpi, whereas a markedly increased frequency and
number of CD4+ Th17 expressing IL-17 were detected in
the CNS of Ccr5−/− mice; being approximately tenfold
higher than those of Ccr5+/+ mice (Fig. 6d). Moreover,
CD4+ T cells sorted from the CNS of Ccr5+/+ mice
showed higher expression of the transcription factors
T-bet and Foxp3, which are involved in the differenti-
ation of CD4+ Th1 cells and Tregs, compared to
those from the CNS of Ccr5−/− mice (Fig. 6e). In con-
trast, CD4+ T cells sorted from the CNS of Ccr5−/− mice
had higher expression of the CD4+ Th17 transcription fac-
tor RORγT and IL-17, compared to Ccr5+/+ mice. These
results suggest that CCR5 ablation results in a skewed IL-
17+CD4+ Th17 response in both extraneural lymphoid tis-
sue and the CNS, which leads to reduced CNS infiltration
of CD4+Foxp3+ Tregs during JE progression, which is
closely associated with exacerbation of JE in Ccr5−/− mice.
CCR5+CD4+Foxp3+ Tregs ameliorate JE progression in
CCR5-ablated mice
Although our results suggest that the increased num-
ber of CD4+Foxp3+ Tregs in extraneural lymphoid tis-
sue and the CNS of Ccr5+/+ mice is associated with
mild JE, we did not provide direct evidence regarding
whether the enhanced response of CD4+Foxp3+ Tregs
plays a beneficial role in JE progression. To address
this issue, CCR5+CD4+Foxp3+ Tregs purified from
Ccr5+/+ mice were injected i.v. into Ccr5−/− mice at
3 dpi, and the recipient mice were examined in terms
of mortality and clinical signs up to 15 dpi. As shown
in Fig. 7a, Ccr5−/− recipients of CCR5+CD4+Foxp3+
Tregs showed a reduced mortality rate (around 50 %)
comparable to that of Ccr5+/+ mice. However, Ccr5−/−
mice that received CCR5−CD4+Foxp3+ Tregs purified
from Ccr5−/−.Foxp3GFP mice showed high susceptibility to
JE, with a mortality rate of 90 %, similar to that of Ccr5−/−
mice. In addition, a reduced proportion of mice showing
neurological disorders was observed in Ccr5−/− recipients
of CCR5+CD4+Foxp3+ Tregs, even though Ccr5−/− recipi-
ents of CCR5+CD4+Foxp3+ Tregs exhibited clinical signs
starting at a similar time post-infection to those of Ccr5−/−
mice and CCR5−CD4+Foxp3+ Treg recipients (Fig. 7b).
Also, Ccr5−/− recipients of CCR5+CD4+Foxp3+ Tregs
showed no apparent reduction in body weight during JE
progression compared to Ccr5−/− mice receiving no Tregs
(Fig. 7c). These results suggest that CCR5+CD4+Foxp3+
Tregs purified from Ccr5+/+·Foxp3GFP mice could amelior-
ate JE progression in Ccr5−/− mice, in contrast with CCR5-
CD4+Foxp3 Tregs purified from Ccr5−/−.Foxp3GFP mice.
To better understand JE regulation in Ccr5−/− mice after in-
jection with CCR5+CD4+Foxp3+ Tregs, the viral burden in
extraneural lymphoid tissues and the CNS was deter-
mined at 5 dpi. Our results revealed that injection of
CCR5+CD4+Foxp3+ Tregs resulted in no change in the
viral burden in Ccr5−/− recipients. This result indicates
that CCR5+CD4+Foxp3+ Tregs could regulate JE pro-
gression without changing the viral burden (Fig. 7d).
Instead, Ccr5−/− recipients of CCR5+CD4+Foxp3+
Tregs showed enhanced expression levels of anti-
inflammatory cytokines, including IL-10 and TGF-β, in the
brain and spleen at 5 dpi, compared to Ccr5−/− mice re-
ceiving no Tregs. However, IL-17 expression was not chan-
ged in the brain and the spleen of CCR5+CD4+Foxp3+
Treg-injected Ccr5−/− recipients (Fig. 7e, f). Collectively,
these results indicate that CCR5+CD4+Foxp3+ Tregs
injected into Ccr5−/− mice ameliorate JE progression by en-
hancing the expression of anti-inflammatory cytokines.
CCR5+CD4+Foxp3GFP Tregs produce IL-10 to ameliorate JE
without altering CNS infiltration of Ly-6Chi monocytes,
CD4+ Th1, or Th17
CCR5+CD4+Foxp3GFP Tregs injected into Ccr5−/− mice
were detected in the CNS and the spleen of recipients,
whereas Ccr5−/− recipients receiving CCR5-CD4+Foxp3+
Tregs contained CCR5−CD4+Foxp3GFP Tregs at a very
low frequency (Fig. 8a, b). This result indicates that
adoptively transferred CCR5+CD4+Foxp3GFP Tregs were
successfully infiltrated into the lymphoid and inflamed
tissues, compared to CCR5−CD4+Foxp3GFP Tregs. To
further characterize CNS inflammation in Ccr5−/− recip-
ients of CCR5+ Tregs, the infiltration of CD11b+Ly-6Chi
monocytes and CD11b+Ly-6Ghi granulocytes into the
CNS was assessed at 5 dpi. Our results revealed that
CCR5+ Treg-injected Ccr5−/− recipients showed no sig-
nificant changes in the frequency of CD11b+Ly6Chi
monocytes and CD11b+Ly-6Ghi granulocytes during JE
progression, compared to those of Ccr5−/− mice
receiving CCR5− Tregs (Fig. 8c). Similarly, injection of
CCR5+CD4+Foxp3GFP Tregs into Ccr5−/− recipients re-
sulted in a moderate but insignificant increase in the
number of CD11b+Ly-6Chi monocytes and CD11b+Ly-
6Ghi granulocytes in the CNS (Fig. 8d). This result indi-
cates that CCR5+CD4+Foxp3GFP Tregs regulate JE progres-
sion in Ccr5−/− mice without affecting CNS infiltration of
CD11b+Ly-6Chi monocytes and CD11b+Ly-6Ghi granulo-
cytes. We also enumerated each CD4+ Th subset in the
CNS. Ccr5−/− recipients of CCR5+CD4+Foxp3+ Tregs had
a higher number of CD4+Foxp3+ Tregs in the CNS at
5 days after infection, compared to Ccr5−/− mice that did










































































































































































































































































































































































Fig. 7 (See legend on next page.)
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Fig. 7 CCR5+CD4+Foxp3+ Tregs ameliorate JE in CCR5-ablated mice. a Susceptibility of CCR5-ablated mice to JE following adoptive transfer of
CCR5+CD4+Foxp3+ Tregs. CCR5+CD4+Foxp3+ and CCR5−CD4+Foxp3+ Treg cells were purified from Ccr5+/+.Foxp3GFP and Ccr5−/−.Foxp3GFP mice
and adoptively transferred to Ccr5−/− mice (n = 10) at 2 days following JEV (3.0 × 107 pfu) infection, respectively. Surviving recipient mice were
examined daily. Ccr5+/+ and Ccr5−/− mice that did not receive Tregs were used as positive and negative controls, respectively. b Ratio of mice
showing neurological disorders in CCR5+ Treg-injected CCR5-ablated mice. Ccr5−/− recipients that received CCR5+ or CCR5− Tregs were examined
every 6 h from 4 to 11 dpi. c Changes in body weight of CCR5+ Treg-injected CCR5-ablated mice during JE. Data are averages ± SD of body
weight relative to the time of challenge. d Viral burden in lymphoid tissue and CNS of Treg-injected Ccr5−/− recipient. Viral burden in the spleen,
brain, and spinal cord of Ccr5−/− recipients was assessed by real-time qRT-PCR at 5 dpi. The viral RNA load was expressed as viral RNA copy
number per microgram of total RNA. e, f The expression of pro- and anti-inflammatory cytokines in lymphoid tissue and CNS of Treg-injected
Ccr5−/− recipients. The expression of pro- and anti-inflammatory cytokines in the brain (e) and spleen (f) of Treg-injected Ccr5−/− recipients was
determined by real-time qRT-PCR at 5 dpi. Data are averages ± SD of values derived from at least three independent experiments (n = 5–6).


































































































































































































































































































































Fig. 8 CCR5+CD4+Foxp3+ Tregs ameliorate JE via IL-10 production without affecting the accumulation of myeloid-derived leukocytes, CD4+ Th1,
or Th17. a, b Detection of CCR5+CD4+Foxp3GFP Tregs in the spleen and brain. Adoptively transferred CCR5+CD4+Foxp3GFP and CCR5−CD4
+Foxp3GFP Tregs were detected by flow cytometry in the spleen (a) and brain (b) at 5 days following JEV (3.0 × 107 pfu) infection. Values in repre-
sentative dot-plots denote the average percentages of CCR5+CD4+Foxp3GFP Tregs in CD4+ T cells. c, d The frequency and number of Ly-6Chi
monocytes and Ly-6Ghi granulocytes in the CNS of CCR5+ or CCR5− Treg-injected CCR5-ablated mice. The frequency (c) and number (d) of
Ly-6Chi monocytes and Ly-6Ghi granulocytes in the CNS of CCR5+ (WT) or CCR5− (KO) Treg-injected CCR5-ablated mice were determined by flow
cytometric analysis at 5 dpi using vigorous heart perfusion. Values in representative dot-plots denote the average percentage of the indicated cell
population after gating on CD11b+ cells. e–h Accumulated number of CD4+ Th1, Th17, and Tregs in the CNS of CCR5+ (WT) or CCR5− (KO)
Treg-injected CCR5-ablated mice. The absolute number of CD4+ Th1, Th17, and Tregs in the CNS and spleen of Treg-injected Ccr5−/− recipients
was determined at 5 dpi. e CD4+Foxp3+ Tregs in brain. f CD4+ Th1 and Th17 in the brain. g CD4+Foxp3+ Tregs in the spleen. h CD4+ Th1 and
Th17 in the spleen. i IL-10 expression in adoptively transferred CCR5+CD4+Foxp3GFP and CCR5−CD4+Foxp3GFP Tregs. The expression of IL-10 in
CNS-infiltrated CCR5+CD4+Foxp3GFP and CCR5−CD4+Foxp3GFP Tregs was evaluated by intracellular IL-10 staining at 5 dpi. Data are averages ± SD
of values derived from at least three independent experiments (n = 3–4). *p < 0.05; **p < 0.01; p < 0.001 compared with the levels of the
indicated groups
Kim et al. Journal of Neuroinflammation  (2016) 13:223 Page 14 of 19
not receive Tregs (Fig. 8e). Numbers of IFN-γ+CD4+ Th1
and IL-17+CD4+ Th17 cells in the CNS of CCR5+ Treg-
injected Ccr5−/− mice were not different compared to in
the CNS of Ccr5−/− mice, which did not receive Tregs
(Fig. 8f). Ccr5+/+ mice had an increased number of IFN-
γ+CD4+ Th1 cells, but reduced number of IL-17+CD4+
Th17 cells compared to Ccr5−/− mice, as shown previously
(Fig. 6d). Similarly, an increased number of CD4+Foxp3+
Tregs was observed in the spleen of CCR5+ Treg-injected
Ccr5−/− recipients, compared to that of Ccr5−/− mice re-
ceiving CCR5− Tregs (Fig. 8g). However, the number of
CD4+Foxp3+ Tregs in Ccr5−/− recipients was lower than
that in Ccr5+/+ mice. In addition, the injection of CCR5
+CD4+Foxp3GFP Tregs in Ccr5−/− mice did not affect the
number of IFN-γ+CD4+ Th1 and IL-17+CD4+ Th17 cells in
the spleen of Ccr5−/− mice during JE progression (Fig. 8h).
Also, a higher proportion of CCR5+CD4+Foxp3GFP and
CCR5−CD4+Foxp3GFP Tregs adoptively transferred into
Ccr5−/− mice were found to produce IL-10, compared to
CD4+Foxp3− Th cells (Fig. 8i). This indicates that IL-10
production is comparable in CCR5+ and CCR5− Tregs
purified from Ccr5+/+·Foxp3GFP and Ccr5−/−·Foxp3GFP
mice. Taken together, these results suggest that
CCR5+CD4+Foxp3+ Tregs injected to Ccr5−/− mice
regulate JE progression by producing IL-10 and en-
hancing infiltration into lymphoid and CNS tissues,
compared to CCR5−CD4+Foxp3+ Tregs.
Discussion
In this study, we evaluated the role of CCR5 in JE progres-
sion. The exacerbation of JE in Ccr5−/− mice was typically
associated with a skewed response to IL-17+CD4+ Th17
cells and correspondingly reduced numbers of CD4+Foxp3+
Tregs in the spleen and brain. We provided evidence that
injection of sorted CCR5+CD4+Foxp3+ Tregs into Ccr5−/−
mice ameliorated JE progression without affecting CNS infil-
tration of IL-17+CD4+ Th17 cells, myeloid-derived Ly-6Chi
monocytes, and Ly-6Ghi granulocytes. Instead, adoptive
transfer of CCR5+CD4+Foxp3+ Tregs into Ccr5−/− mice in-
creased the expression levels of two anti-inflammatory cyto-
kines, IL-10 and TGF-β, in the spleen and brain. Our results
suggest that CCR5 regulates the progression of viral enceph-
alitis via governing a timely and an appropriate CNS infiltra-
tion of CD4+Foxp3+ Tregs and ultimately promoting
survival of hosts suffering severe neuroinflammation.
CD4+Foxp3+ Tregs are believed to maintain host
immune homeostasis by actively suppressing patho-
logical and physiological immune responses after
homing to inflamed tissues in response to the pres-
ence of foreign antigens [21–24]. A putative and
somewhat contradictory role of CD4+Foxp3+ Tregs
has been demonstrated in various models of patho-
genic infections [23–26]. A putative correlation be-
tween CD4+Foxp3+ Treg levels and the outcome of
infectious disease has been reported in WNV enceph-
alitis because patients with symptomatic infection have
lower CD4+Foxp3+ Treg frequencies throughout the infec-
tion compared to asymptomatic patients [25]. In addition, a
correlation of CD4+Foxp3+ Tregs with the outcome of flavi-
virus infection has been reported; Treg expansion but not
absolute level was lower in children with severe dengue dis-
ease [26]. However, the factors involved in amelioration by
CD4+Foxp3+ Treg of severe flavivirus-induced disease are
unclear. Our results suggest a role for CCR5 in regulating
JE progression by mediating CD4+Foxp3+ Treg homing,
subsequently inducing skewed IL-17+CD4+ Th17 re-
sponses in lymphoid and inflammatory tissues.
Furthermore, considering that asymptomatic and symp-
tomatic populations have similar CD4+Foxp3+ Treg fre-
quencies prior to WNV infection, while asymptomatic
patients exhibit greater Treg expansion within the first
2 weeks of infection [25], the proliferation and/or differen-
tiation of CD4+Foxp3+ Tregs in asymptomatic persons
seems to be promoted by unknown factors (molecular or
cellular components) derived from WNV infection. The
expanded Tregs then migrate into inflammatory tissues by
means of homing receptors such as CCR5, thereby pro-
moting host survival. In line with this notion, the expan-
sion of CD4+Foxp3+ Tregs in JEV-infected Ccr5+/+ mice
was around two-fold higher at 5 dpi, and the TLR4 signal-
ing pathway is likely to be involved in their expansion in a
JE model [27]. Also, the impact of CCR5 in CD4+Foxp3+
Treg proliferation and its regulatory role in Treg homing
have been clearly demonstrated in a parasitic model [39].
CCR5-dependent recruitment of CD4+Foxp3+ Tregs may
dictate the magnitude of the CD4+ Th1 and/or Th17
subset responses to favor a detrimental or beneficial
effect on pathogen persistence at the site of infection
[23, 24, 40, 41]. Our results favor a beneficial role for
CD4+Foxp3+ Tregs in ameliorating severe neuroin-
flammation caused by JEV infection, depending on
CCR5-mediated homing to inflammatory tissue.
Therefore, CCR5 is involved in the putative role of
CD4+Foxp3+ Tregs in severe flavivirus-induced dis-
eases, such as encephalitis and hemorrhagic fever.
The role of CCR5 in infectious diseases is variable in
terms of its impact on pathogenesis and disease out-
come. An essential role of CCR5 in ameliorating the out-
come of infectious diseases has been documented in
trypanosomiasis [42], toxoplasmosis [43], genital herpes
[44], influenza [45], flaviviral West Nile encephalitis, and
JE [16–18], while a beneficial effect of CCR5 deficiency
on the outcome of other infectious diseases has been
postulated [23, 24, 39, 46, 47]. Mechanistically, these
variable outcomes of CCR5 deficiency in infectious dis-
eases have been largely attributed to its regulatory effect
on trafficking of leukocytes, including NK, CD4, CD8,
and CD4+Foxp3+ Treg cells to the site of infection as a
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consequence of the elevated immunopathology. There-
fore, this dichotomy in the role of CCR5 in regulating
the outcome of infectious diseases prevents the
generalization of our findings of the impact of chemo-
kine receptors in disease prognosis. Nevertheless, CCR5
is believed to play a crucial role in protection against se-
vere neuroinflammation caused by flavivirus infections
[16–18]. In this study, we also confirmed an essential
role for CCR5 in regulating JE progression. However,
CCR5 deficiency failed to alter or increase the viral bur-
den in extraneural tissue (spleen) and the CNS. The
activation of innate NK cells was increased in Ccr5−/−
mice, rather than in Ccr5+/+ mice, as corroborated by
enumeration of the IFN-γ-producing NK cells. In
contrast, Ccr5+/+ mice showed a transiently higher
number of CNS-infiltrated NK cells with a loss of
CD3−NK1.1+DX5+ NK cells in the spleen and blood
of both Ccr5+/+ and Ccr5−/− mice after JEV infection.
Although survived Ccr5+/+ mice displayed moderately
increased responses of JEV-specific CD4+ T cells at
7 dpi, Ccr5−/− mice showed a much higher frequency
and number of JEV-specific CD8+ T cells in response
to stimulation with JEV antigen. These split innate
and adaptive immune responses of Ccr5−/− mice dur-
ing JE progression are contradictory to a previous
report that NK cell responses and CD4+ as well as
CD8+ T cell responses decreased in Ccr5−/− mice fol-
lowing JEV infection [17]. The discrepancy might be
due to differences in the genetic background and age
of the host, strain and dosage of virus, and the route
of challenge. Indeed, because Ccr5+/+ and Ccr5−/−
mice began to show clinical signs, such as neuro-
logical disorders, at 3–5 dpi, which is before func-
tional adaptive immune responses were fully induced,
the JE model used in this study appeared to have
more acute and rapid progression than that in a pre-
vious study, in which clinical signs were observed at
8–10 dpi [17]. This accelerated and rapid progression
of JE in Ccr5+/+ and Ccr5−/− mice might have re-
sulted in induction of distinct NK and CD4/CD8 T
cell responses in the host. Early regulation of severe
neuroinflammation in the CNS through regulatory
mechanisms such as CD4+Foxp3+ Tregs and myeloid-
derived suppressor cells (MDSC) may be important
for host survival in cases of acute and rapid progres-
sion of JE. This notion is strengthened by the result
that Ccr5+/+ and Ccr5−/− mice showed similar splenic
CD4+ and CD8+ immune responses in a WNV infection
model, to which mice are highly susceptible compared to
humans [16]. Also, the fact that CD4+Foxp3+ Tregs can
regulate the progression of WNV encephalitis in an infec-
tion model using depletion of CD4+Foxp3+ Treg cells sug-
gests an important role for CD4+Foxp3+ Tregs in
regulating the progression of fatal neuroinflammation
caused by flaviviruses [25]. In this study, the regulatory role
of CD4+Foxp3+ Tregs in JE progression was clarified by
adoptive transfer of CCR5+CD4+Foxp3+ Tregs in Ccr5−/−
mice. This is strongly supported by a recent report that
Tregs can ameliorate encephalitis by repressing effector T
cell function [48]. However, the CCR5-mediated regulatory
function of CD4+Foxp3+ Tregs was likely to be relatively
unimportant in JE progression, because adoptive transfer of
CCR5+CD4+Foxp3+ Tregs between 2 and 4 dpi ameliorated
JE progression, whereas CD4+Foxp3+ Tregs that were adop-
tively transferred prior to JEV infection rendered the recipi-
ents vulnerable to JE (unpublished personal data).
Therefore, we used adoptive transfer of CCR5+CD4+Foxp3+
Tregs in Ccr5−/− mice at 3 dpi, the time point at which in-
fected mice began to show clinical signs, such as general-
ized piloerection, paresis, and rigidity. Although further
study is warranted, CCR5 appears to play a non-committed
role in JE progression by regulating the trafficking equilib-
rium of effector leukocytes and regulatory CD4+Foxp3+
Tregs, depending on disease progression.
It is likely that our results discount the role of CCR5 in
ameliorating JE progression by CNS infiltration of effector
leukocytes such as NK cells, macrophages, CD4+ cells,
and CD8+ T cells. It has long been assumed that leukocyte
infiltration into the CNS is critical for clearing virus and
aiding recovery. CCR5 deficiency was associated with in-
creased flavivirus burden in the CNS but not in extra-
neural tissues, which was mechanistically mediated by
inappropriate CNS infiltration of leukocytes [16, 17].
However, the critical role of CCR5 in flavivirus pathogen-
esis appears to be unique in other neurotropic viruses, be-
cause infections of Ccr5−/− mice with several neurotropic
viruses, such as LCMV [49], retrovirus FR98 [50], and
mouse hepatitis virus (MHV) [51], resulted in viral bur-
dens in the CNS similar to those of Ccr5+/+ mice. Unlike
earlier works on flavivirus encephalitis [16, 17], the
present study showed that the JEV burden in the extra-
neural tissue and CNS of Ccr5+/+ mice was similar to that
in Ccr5−/− mice, with transiently and early increased CNS
infiltration of NK and CD4+ cells, but not CD8+ T cells, in
Ccr5+/+ mice. Although the mechanisms of increased
CNS infiltration of leukocytes in Ccr5−/− mice with an un-
changed viral burden need to be defined, the JE model
used appears to affect the dynamics of leukocyte CNS in-
filtration and the subsequent viral burden. CNS trafficking
of Ly-6Chi monocytes and Ly-6Ghi granulocytes is medi-
ated through a multistep process governed by CC and
CXC chemokines. In support, the enhanced expression of
CC chemokines including CCL2, CCL3, CCL4, and CCL5
appeared to facilitate CNS infiltration of Ly-6Chi mono-
cytes in Ccr5−/− mice at the early phase, although whether
these cells function to suppress or promote pathogenesis
is unclear [52, 53]. One interesting result in this study was
the reversal of CXC chemokine expression between 3 and
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5 dpi. Although CXCL1 and CXCL2 play a dominant role
in the trafficking of Ly-6Ghi granulocytes, CC chemokines
are also likely to be involved in CNS infiltration of Ly-
6Ghi granulocytes [54]. Furthermore, increased CNS infil-
tration of Ly-6Ghi granulocytes in Ccr5−/− mice is
strengthened by the result that CCR5 ablation increases
the recruitment of Ly-6Ghi granulocytes in herpetic en-
cephalitis [55]. Also, it is conceivable that CXCL2 is in-
volved in the recruitment of granulocytic MDSCs at a
later stage [56], thereby resulting in the amelioration of JE
progression. However, CCR5 appeared not to be involved
in the migration of myeloid and lymphoid cells from the
blood into the brain, because the accumulation of myeloid
(monocytes, granulocytes) and lymphoid (NK, CD4/CD8
T cells) cells in the blood showed similar patterns to those
in the brain. These data are in line with a previous report
that CCR2 is not involved in monocyte migration from
the blood into the brain [57]. CCR5 ablation may cause
accumulation of CCR5 ligands (CCL3, CCL4, CCL5) via
their compensation mechanism [58], which could induce
dysregulation of the migration of monocytes, NK cells,
and T cells expressing cognate receptors (CCR1, CCR3).
Also, the appropriate adaptive CD4+ and CD8+ T cell re-
sponses can be achieved by orchestrated chemokine ex-
pression in secondary lymphoid tissues to promote
contact between T and dendritic cells [59]. Indeed, our re-
sults demonstrate unexpected adaptive JEV-specific CD4+
and CD8+ T cell responses in Ccr5−/− mice; stronger
responses of JEV-specific CD4+ T cells were induced in
Ccr5+/+ mice, whereas Ccr5−/− mice displayed a potent
JEV-specific CD8+ T cell response. Ultimately, these spec-
ulations suggest that other chemokine receptors may be
involved in the migration of myeloid and lymphoid cells
as well as adaptive T cell responses in a CCR5-ablated en-
vironment, due to redundancy and compensation of che-
mokines and their receptors. In addition, the role of NK
and CD8+ T cells in CNS clearance of JEV remains elusive,
because the depletion or adoptive transfer of NK and
CD8+ T cells does not contribute significantly to host
survival or viral clearance [36]. Also, although IFN-
γ+CD4+ Th1 cells are believed to play a role in regu-
lating JE progression by reducing viral burden in the
CNS [38], only co-transfer of immune CD4+ and CD8+ T
cells, not individual transfer of either T cell subpopulation,
significantly ameliorates JE progression and promotes host
survival [37]. These facts support the possibility that tran-
siently and early increased CNS infiltration of NK and
IFN-γ+CD4+ Th1 cells in Ccr5+/+ mice may not be suffi-
cient for viral clearance from the CNS, resulting in a simi-
lar CNS viral burden in Ccr5+/+ and Ccr5−/− mice.
Therefore, balanced and orchestrated CNS infiltration by
innate NK and adaptive T cell subpopulations likely medi-
ates viral clearance, thereby providing protection against
JE progression without tissue injury.
IL-17 is produced mainly by IL-17+CD4+ Th17 cells. It
plays a critical role in autoimmune and virus-caused im-
munopathologic diseases by facilitating neutrophil recruit-
ment [60–62]. In contrast, IL-17 appears to play a minor
role in protective immunity against parasitic infection [63]
but a more important role in fungal infection in a
CCR5-ablated environment [39]. In the present
study, CD4+Foxp3+ Tregs did not directly regulate
CNS recruitment of IL-17+CD4+ Th17 cells or their
IL-17 production. In addition, adoptive transfer of
CCR5+CD4+Foxp3+ Tregs did not influence CNS in-
filtration of Ly-6Chi monocytes and Ly-6Ghi granulo-
cytes. However, the anti-inflammatory cytokines IL-
10 and TGF-β produced by adoptively transferred
CCR5+CD4+Foxp3+ Tregs might have played a role
in regulating JE progression. This notion is sup-
ported by the finding that insufficient anti-
inflammatory cytokine levels are associated with ex-
acerbated JE [64]. Furthermore, our data are strongly
supported by the finding that IL-10 ablation exacer-
bates alphavirus encephalomyelitis by enhancing
CNS infiltration of IL-17+CD4+ Th17 and IFN-
γ+CD4+ Th1 cells, without affecting the amount of
brain inflammation and viral replication [65]. Indeed, the
majority of adoptively transferred CCR5+CD4+Foxp3+
Tregs in Ccr5−/− mice produced IL-10. Furthermore, gen-
eration of CD4+Foxp3+ Tregs and IL-17+CD4+ Th17 cells
is reciprocally regulated [60–62]. This developmental link
between CD4+Foxp3+ Tregs and IL-17+CD4+ Th17 cells
has led to speculation that these T cell subsets exist in
equilibrium during inflammation and infection [66, 67].
However, this equilibrium was disturbed, thereby causing
exacerbation of JE progression in Ccr5−/− mice. Therefore,
our results provide insight into the utility of IL-10 and
CD4+Foxp3+ Tregs for regulating JE progression by
maintaining the balance between CD4+Foxp3+ Tregs and
IL-17+CD4+ Th17 cells at specific time points.
Conclusions
CCR5 could regulate JE progression via mediating the equi-
librium between CD4+Foxp3+ Tregs and IL-17+CD4+ Th17
cells without causing tissue injury. This critical and
extended role of CCR5 in flavivirus-induced diseases raises
possible safety concerns regarding the use of CCR5 antago-
nists in HIV individuals who inhabit regions where both
HIV and flaviviruses such as JEV and WNV are endemic
[68]. Therefore, understanding the detailed role of CCR5 in
the pathogenesis of flavivirus-caused encephalitis will be
important to prevent any potential risk to HIV-positive in-
dividuals who take CCR5 antagonists with curative intent.
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